Recently added

VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN

Bomback, Andrew; Delmas, Yahsou; Dixon, Bradley; Gale, Daniel; Nester, Carla; Ariceta Iraola, Gema (Elsevier, 2025-07)

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study

Sester, Martina; Altet-Gómez, Neus; Andersen, Aase Bengaard; Arias-Guillén, Miguel; Avsar, Korkut; Bakken Kran, Anne-Marte; de Souza Galvão, Maria Luiza (Elsevier, 2025-10)

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1

Ruiz , Manuel ; Vaklavas, Christos; Baird, Richard; BERMEJO, BEGOÑA; Moreno, Irene; Oliveira, Mafalda (American Association for Cancer Research, 2025-10-15)

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment

Stahl, Andreas; Nakanishi, Hidehiko; Lepore, Domenico; Wu, Wei-Chi; Azuma, Noriyuki; Jacas, Carlos (SAGE Publications, 2025-08)

Case Report: Combined Intercostal-Transdiaphragmatic-Abdominal Wall Hernia

Rodrigues Gonçalves, Victor; Martín del Rey, Alba; Martinez-Lopez, Pilar; VERDAGUER TREMOLOSA, MIREIA; LOPEZ-CANO, MANUEL (Frontiers Media, 2025-07-04)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

HVH - Articles científics: Recent submissions

VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment

Case Report: Combined Intercostal-Transdiaphragmatic-Abdominal Wall Hernia

Scientia. Dipòsit d'Informació Digital del Departament de Salut

HVH - Articles científics: Recent submissions

VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN ﻿

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study ﻿

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1 ﻿

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment ﻿

Case Report: Combined Intercostal-Transdiaphragmatic-Abdominal Wall Hernia ﻿

VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN

Diagnostic accuracy and predictive value of the QuantiFERON-TB gold plus assay for tuberculosis in immunocompromised individuals: a prospective TBnet study

Camizestrant in Combination with Three Globally Approved CDK4/6 Inhibitors in Women with ER+, HER2- Advanced Breast Cancer: Results from SERENA-1

Plain-language commentary: 2-year findings from the FIREFLEYE next study looking at how well aflibercept injected into affected eyes in babies with retinopathy of prematurity works and how safe it is compared with laser treatment

Case Report: Combined Intercostal-Transdiaphragmatic-Abdominal Wall Hernia